Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 9.21 percent decrease over losses of $(0.76) per share from the same period last year.
$1000 Invested In Archer-Daniels Midland 20 Years Ago Would Be Worth This Much Today
Archer-Daniels Midland (NYSE:ADM) has outperformed the market over the past 20 years by 1.58% on an annualized basis…